dc.contributor.author |
Kristinsson, Karl Gústaf |
dc.date.accessioned |
2022-11-24T01:04:22Z |
dc.date.available |
2022-11-24T01:04:22Z |
dc.date.issued |
2022-03-03 |
dc.identifier.citation |
Kristinsson , K G 2022 , ' Þögli faraldurinn – sýklalyfjaónæmi ' , Læknablaðið , bind. 108 , nr. 3 , bls. 119 . https://doi.org/10.17992/lbl.2022.03.678 |
dc.identifier.issn |
1670-4959 |
dc.identifier.other |
62659323 |
dc.identifier.other |
4461731e-9985-40bd-8a7a-59d401349cbc |
dc.identifier.other |
35230255 |
dc.identifier.other |
85125552693 |
dc.identifier.other |
unpaywall: 10.17992/lbl.2022.03.678 |
dc.identifier.uri |
https://hdl.handle.net/20.500.11815/3659 |
dc.format.extent |
1 |
dc.format.extent |
682679 |
dc.format.extent |
119 |
dc.language.iso |
is |
dc.relation.ispartofseries |
Læknablaðið; 108(3) |
dc.rights |
info:eu-repo/semantics/openAccess |
dc.subject |
Sýklafræði |
dc.subject |
Sýklalyfjaónæmi |
dc.subject |
Anti-Bacterial Agents/adverse effects |
dc.subject |
COVID-19 |
dc.subject |
Drug Resistance, Bacterial |
dc.subject |
Humans |
dc.subject |
Pandemics |
dc.subject |
SARS-CoV-2 |
dc.subject |
Drug Resistance, Microbial |
dc.subject |
Almenn læknisfræði |
dc.title |
Þögli faraldurinn – sýklalyfjaónæmi |
dc.title.alternative |
The silent pandemic - antimicrobial resistance |
dc.type |
/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/editorial |
dc.identifier.doi |
10.17992/lbl.2022.03.678 |
dc.relation.url |
http://www.scopus.com/inward/record.url?scp=85125552693&partnerID=8YFLogxK |
dc.contributor.department |
Læknadeild |
dc.contributor.department |
Önnur svið |
dc.contributor.department |
Rannsóknaþjónusta |